Swedish maker of custom plastic and silicone components for medical, telecom, consumer and industrial customers.
Swedish maker of custom plastic and silicone components for medical, telecom, consumer and industrial customers.
Makes parts to a customer's drawings and is paid per part, with long supply programmes once a design is validated. Medical and healthcare products require validated manufacturing and tend to be steadier than consumer electronics enclosures.
In one line: A precision plastics/silicone molder like a smaller Nypro.
Moat: narrow (process know-how, customer qualification). Precision molding and regulatory-compliant medical manufacturing create switching costs once qualified.
Headquarters: Torekov, Sweden · Founded: 1938
Size Nolato (NOLA-B.ST) is a Sweden Information Technology company (Electronic Production Equipment) with a market value of $1.40B, the 109th largest of 221 Sweden companies the cockpit tracks. Shares closed at SEK 50.90 on 6 Nov 2026.
Performance Over six months the shares gained 5.5%, against -27.2% for the median peer and +8.2% for the Sweden market (cap-weighted) — highest of 20 in its peer set.
Growth Revenue grew 0.1% over the last twelve months (peer median +17.5%); the operating margin is 10.0% (peer median 8.5%).
Valuation It trades at 18.8× forward earnings against a peer median of 19.3× (6th cheapest of 11).
Price implies For today's price to make sense, revenue must grow about 4% a year for seven years (Req g). Recent delivered growth is 0%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 5.3 points above its cost of capital (7.1% WACC).
Next results Next results expected around 8 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | SEK 9.58B | SEK 9.46B | SEK 9.66B | SEK 9.55B | SEK 10.8B |
| Revenue growth | — | -2% | +1% | -11% | — |
| Gross profit | SEK 1.74B | SEK 2.24B | SEK 2.15B | SEK 1.82B | SEK 2.05B |
| EBITDA | SEK 1.53B | SEK 1.54B | SEK 1.49B | SEK 1.24B | SEK 1.37B |
| Net income | SEK 673M | SEK 777M | SEK 658M | SEK 435M | SEK 697M |
| Free cash flow | n/a | SEK 278M | SEK 742M | SEK 355M | -SEK 45.0M |
| Capital expenditure | n/a | SEK 789M | SEK 640M | SEK 430M | SEK 455M |
| Total debt | SEK 749M | SEK 1.45B | SEK 1.53B | SEK 1.88B | SEK 2.03B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Nolato NOLA-B.ST | $1.40B | +5% | 0% | 10% | 18.8× | 3.9% |
| Jabil JBL | $24.6B | -33% | +21% | 5% | 13.5× | 8.3% |
| Flex FLEX | $25.8B | -51% | +18% | 6% | 11.2× | 15.9% |
| West Pharmaceutical Services WST | $27.9B | +23% | +13% | 23% | 39.8× | 25.2% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | NOLA-B.ST | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -9.6% | -19.8% | 9th highest of 21 |
| 6-month return | +5.5% | -27.2% | highest of 20 |
| Distance from 52-week high | -18.9% | -51.1% | 3rd highest of 21 |
| Revenue growth (TTM) | +0.1% | +17.5% | 4th lowest of 21 |
| Operating margin | 10.0% | 8.5% | 9th highest of 21 |
| Forward P/E | 18.8× | 19.3× | 6th cheapest of 11 |
| Growth the price implies (Req g, 7 yrs) | 3.9% | 15.3% | 3rd least demanding of 13 |
| Growth delivered (Del g) | +0.2% | +7.6% | 3rd lowest of 13 |
| Hurdle (Req g minus delivered) | +3.6 pp | +4.5 pp | 7th least demanding of 13 |
| ROIC minus cost of capital | +5.3 pp | -2.9 pp | 4th highest of 21 |
| EV / EBITDA | 9.1× | 12.4× | 2nd cheapest of 4 |
| Net debt / EBITDA | 0.1× | -1.2× | most indebted of 4 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Nolato NOLA-B.ST | Sweden | $1.40B | +5% | 0% | 10% | 18.8× | 3.9% | +0.2% |
| TKD Science and Technology 603738.SS | China | $1.39B | -37% | +20% | 9% | 42.5× | 44.4% | +8.4% |
| TPV Technology 000727.SZ | China | $1.38B | -23% | +7% | -1% | n/a | n/a | n/a |
| Suzhou Betely Polymer Materials 301697.SZ | China | $1.44B | n/a | +45% | 5% | n/a | n/a | n/a |
| Shenzhen Success Electronics 002289.SZ | China | $1.33B | -9% | +237% | 27% | n/a | 24.4% | +18.8% |
| Dongguan Tarry Electronics 300976.SZ | China | $1.33B | +4% | +19% | 9% | 15.3× | 17.5% | +27.2% |
| Doosan Fuel Cell 336260.KS | South Korea | $1.33B | -56% | -19% | -31% | n/a | n/a | n/a |
| TXC 3042.TW | Taiwan | $1.28B | -26% | +9% | 17% | 14.4× | 10.7% | +3.9% |
| Grand Process Technology 3131.TWO | Taiwan | $1.27B | -51% | +38% | 22% | 18.3× | 13.0% | +21.2% |
| Shenzhen Hui Chuang Da Technology 300909.SZ | China | $1.26B | +4% | +3% | 2% | n/a | n/a | n/a |
| Maxvision Technology 002990.SZ | China | $1.26B | -39% | +36% | 14% | n/a | n/a | n/a |
| Shenzhen Sinexcel Electric 300693.SZ | China | $1.57B | -28% | +27% | 15% | 17.2× | 13.1% | +35.0% |
| WindSun Science & Technology 688663.SS | China | $1.23B | -14% | -9% | 3% | 36.5× | 48.5% | +18.9% |
| Aurora Optoelectronics 600666.SS | China | $1.22B | -44% | +44% | -15% | n/a | 35.2% | -1.9% |
| Photronics PLAB | United States | $1.61B | -49% | +1% | 22% | 13.3× | 1.9% | +6.9% |
| Fuman Microelectronics 300671.SZ | China | $1.21B | -22% | +71% | 3% | n/a | n/a | n/a |
| Shenzhen Fenda Technology 002681.SZ | China | $1.19B | -15% | +7% | -1% | n/a | 27.1% | -5.2% |
| CTS CTS | United States | $1.65B | -6% | +7% | 16% | 20.3× | 8.5% | +5.0% |
| Dongjin Semichem 005290.KS | South Korea | $1.18B | -44% | -4% | 16% | n/a | -4.4% | +5.0% |
| Beijing Relpow Technology 300593.SZ | China | $1.68B | -27% | +16% | -14% | 286.9× | n/a | n/a |
| Guangdong Suqun New Material 301489.SZ | China | $1.16B | -54% | +24% | 8% | 53.2× | n/a | n/a |